Centene Corporation
HealthcareNYSE:CNC · New York Stock Exchange
+$2.06 today
Vol 4.78M · Avg 6.36M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $21.3B |
| Short-term Investments | $2.5B |
| Receivables | $19.4B |
| Other Current | $1.8B |
| Total Current Assets | $45.0B |
| PP&E (Net) | $2.1B |
| Goodwill | $10.8B |
| Intangible Assets | $4.4B |
| Long-term Investments | $16.6B |
| Other Non-current | $2.3B |
| Total Non-current Assets | $36.2B |
| Total Assets | $81.2B |
Analysis
Selected assets total $81.2B for Latest. The largest visible component is Cash & Equivalents at $21.3B, about 26.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.9B +27.2% | $14.1B -18.2% | $17.2B +42.4% | $12.1B -8.0% | $13.1B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 -100.0% | $2.6B +6.6% | $2.5B +5.9% | $2.3B +50.8% | $1.5B | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $18.1B -8.2% | $19.7B +26.9% | $15.5B +17.0% | $13.3B +8.4% | $12.2B | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 -100.0% | $1.6B -71.3% | $5.6B +126.4% | $2.5B +53.6% | $1.6B | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $36.0B -5.3% | $38.0B -6.8% | $40.8B +35.3% | $30.1B +5.7% | $28.5B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.4B -3.0% | $2.4B +0.5% | $2.4B -51.6% | $5.0B -28.3% | $7.0B | $1.2B | $1.5B | $687.8M |
| Goodwill | $10.8B -38.3% | $17.6B +0.0% | $17.6B -6.7% | $18.8B -4.9% | $19.8B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $4.5B -16.3% | $5.4B -11.3% | $6.1B -11.7% | $6.9B -11.7% | $7.8B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $20.9B +19.8% | $17.4B +7.0% | $16.3B +10.9% | $14.7B +4.6% | $14.0B | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $914.0M | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $2.2B +32.8% | $1.6B +6.5% | $1.5B +13.0% | $1.3B +5.1% | $1.3B | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $41.7B -6.3% | $44.4B +1.3% | $43.9B -6.1% | $46.7B -6.3% | $49.9B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $77.7B -5.8% | $82.4B -2.6% | $84.6B +10.1% | $76.9B -1.9% | $78.4B | $13.3B | $11.9B | $10.6B |
| Account Payables | $20.5B +57.8% | $13.0B -19.9% | $16.3B +73.9% | $9.3B +12.7% | $8.3B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $196.0M +78.2% | $110.0M -7.6% | $119.0M +45.1% | $82.0M -69.3% | $267.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $736.0M +11.3% | $661.0M -7.6% | $715.0M +49.6% | $478.0M +10.1% | $434.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | -$50.0M -100.3% | $18.3B +1.7% | $18.0B +7.5% | $16.7B +17.6% | $14.2B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $21.5B -37.3% | $34.3B -6.7% | $36.7B +29.0% | $28.5B +10.5% | $25.8B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $18.0B -2.5% | $18.4B +4.0% | $17.7B -1.3% | $17.9B -3.4% | $18.6B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $1.7B +155.4% | $684.0M +6.7% | $641.0M +4.2% | $615.0M -56.3% | $1.4B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $15.8B +763.9% | $1.8B -33.2% | $2.7B +10.3% | $2.5B +24.7% | $2.0B | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $36.1B +66.7% | $21.7B -1.3% | $22.0B -9.1% | $24.2B -5.5% | $25.6B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $57.6B +3.0% | $55.9B -4.7% | $58.7B +11.5% | $52.6B +2.5% | $51.4B | $14.7B | $3.7B | $9.6B |
| Common Stock | $1.0M +0.0% | $1.0M +0.0% | $1.0M +0.0% | $1.0M +0.0% | $1.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $8.7B -43.5% | $15.3B +27.4% | $12.0B +28.9% | $9.3B +14.8% | $8.1B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$58.0M +88.5% | -$504.0M +22.7% | -$652.0M +42.4% | -$1.1B -1570.1% | $77.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $103.0M +3.0% | $100.0M -13.8% | $116.0M -35.6% | $180.0M -20.7% | $227.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $20.1B -24.3% | $26.5B +2.1% | $26.0B +7.1% | $24.2B -10.3% | $27.0B | $9.1B | $7.7B | $3.3B |
| Total Debt | $18.8B -3.4% | $19.4B +2.9% | $18.9B -11.5% | $21.3B -5.9% | $22.7B | $724.2M | $410.6M | $399.4M |
| Net Debt | $889.0M -83.4% | $5.4B +218.6% | $1.7B -81.8% | $9.3B -3.0% | $9.5B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Illumina, Inc.
NASDAQ:ILMN
$24.35B
Royalty Pharma plc
NASDAQ:RPRX
$23.71B
Hologic, Inc.
HOLX
$16.97B
Genmab A/S
NASDAQ:GMAB
$15.35B
Tenet Healthcare Corporation
NYSE:THC
$15.29B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.40B
Smith & Nephew plc
NYSE:SNN
$12.96B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.35B
Universal Health Services, Inc.
NYSE:UHS
$9.22B
Tempus AI, Inc.
NASDAQ:TEM
$8.30B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does CNC have?
Centene Corporation (CNC) reported $17.89B in cash and equivalents in fiscal 2025.
How much debt does CNC carry?
Centene Corporation (CNC) reported $18.78B of total debt, with net debt of $889.00M.
Explore More
Continue the stock analysis
Jump to another research area for this company.